DRKS00031547招募中不适用
Extended monitoring and success evaluation of percutaneous catheter-supported AV valve interventions using pulse contour analysis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Therapy of severe AV valve regurgitation by percutaneous catheter-based intervention.
- •- Capacity to consent
排除标准
- •- Pre-existing circulatory disorders of the upper extremities
- •- Emergency intervention
- •- Cardiogenic shock
- •- Lack of informed consent for study participation
研究者
相似试验
已完成
不适用
Progress monitoring for the evaluation of complications that occur in direct or indirect connection with the compression therapy / thrombin injection to treat catheter-associated complications (pseudoaneurysm)I72.4Aneurysm and dissection of artery of lower extremityDRKS00009961Gefäßzentrum Klinikum Darmstadt GmbH238
进行中（未招募）
不适用
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing RegimensEUCTR2009-016560-36-PLF. Hoffmann-La Roche Ltd650
进行中（未招募）
不适用
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing RegimensChronic Hepatitis CMedDRA version: 14.1Level: LLTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2009-016560-36-ATF. Hoffmann-La Roche Ltd650
进行中（未招募）
1 期
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing RegimensChronic Hepatitis CMedDRA version: 14.1Level: PTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2009-016560-36-DEF. Hoffmann-La Roche Ltd650
进行中（未招募）
不适用
A long-term monitoring study to evaluate the persistence of direct acting antiviral (DAA) treatmentresistant mutations or the durability of sustained virological response (SVR) in patients treated with DAAcontaining regimens for chronic hepatitis C infection (CHC). - NDChronic Hepatitis CMedDRA version: 9.1Level: LLTClassification code 10008912EUCTR2009-016560-36-ITF. Hoffmann-La Roche Ltd650